ECOR1 CAPITAL, LLC purchased 86.5% of their position (4.96M shares) of ITEOS THERAPEUTICS, INC. on the open market
Open‑market purchase worth $38.69M — a major conviction buy. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 5/16/2025ACC: 0000935836-25-000384
10% Owner
Since May 2025
+4.96M
Net shares
Net buyer
$38.69M
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
4.96M acquired
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+1.66M
Price / share
$7.41
Trade value
$12.29M
% of position
29.0%
5/14/2025
5.73M→7.39M
Common Stock
Indirect
Shares
+3.30M
Price / share
$8.00
Trade value
$26.40M
% of position
44.7%
5/15/2025
7.39M→10.69M
Total
Net shares
+4.96M
Net value
$38.69M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 5/14/2025 | P · Purchase | +1.66M | $7.41 | $12.29M | 29.0% | 5.73M | 7.39M |
| Common Stock Indirect | 5/15/2025 | P · Purchase | +3.30M | $8.00 | $26.40M | 44.7% | 7.39M | 10.69M |
| Total | +4.96M | $38.69M | ||||||
Derivative Transactions0
No derivative transactions reported